O. S. Weislow
- Virology top 0.5%
- Infectious Diseases top 1%
- Molecular Biology top 10%
- Immunology top 5%
- Epidemiology top 5%
- Co-authors
- Michael R. BoydJohn P. BaderRebecca KiserRobert H. ShoemakerDonald L. FineJames B. McMahonKirk R. GustafsonJohn H. Cardellina
- Topics
- HIV Research and Treatment (26 papers)HIV/AIDS drug development and treatment (17 papers)Virus-based gene therapy research (9 papers)
- Partner nations
- United StatesNorwayItaly
In The Last Decade
O. S. Weislow
48 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Virology 1.4k
- Infectious Diseases 1.1k
- Molecular Biology 840
- Immunology 801
- Epidemiology 499
Countries citing papers authored by O. S. Weislow
This map shows the geographic impact of O. S. Weislow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. S. Weislow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. S. Weislow more than expected).
Fields of papers citing papers by O. S. Weislow
This network shows the impact of papers produced by O. S. Weislow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. S. Weislow. The network helps show where O. S. Weislow may publish in the future.
Co-authorship network of co-authors of O. S. Weislow
This figure shows the co-authorship network connecting the top 25 collaborators of O. S. Weislow. A scholar is included among the top collaborators of O. S. Weislow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. S. Weislow. O. S. Weislow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 12 | |
| 5 | 8 | |
| 6 | 68 | |
| 7 | 354 | |
| 8 | 37 | |
| 9 | 48 | |
| 10 | 86 | |
| 11 | 162 | |
| 12 | 89 | |
| 13 | Sulfonic acid dyes: inhibition of the human immunodeficiency virus and mechanism of action. | 25 |
| 14 | 15 | |
| 15 | 4 | |
| 16 | 24 | |
| 17 | 210 | |
| 18 | 201 | |
| 19 | 9 | |
| 20 | 4 |
About O. S. Weislow
O. S. Weislow is a scholar working on Virology, Infectious Diseases and Immunology, having authored 51 papers that have together received 3.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (26 papers), HIV/AIDS drug development and treatment (17 papers) and Virus-based gene therapy research (9 papers). The work is most often cited by research in Virology (1.4k citations), Infectious Diseases (1.1k citations) and Immunology (801 citations). O. S. Weislow has collaborated with scholars based in United States, Norway and Italy. Frequent co-authors include Michael R. Boyd, John P. Bader, Rebecca Kiser, Robert H. Shoemaker, Donald L. Fine, James B. McMahon, Kirk R. Gustafson, John H. Cardellina, Bruce L. Levine and James L. Riley. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.